Synthesis of novel celluloses derivatives and investigation of their mitogenic activity in the presence and absence of FGF2

Acta Biomaterialia

Volumn 6, Issue 6, 2010, Pages 2116-2125

  Peschel, D ^a   Zhang, K ^b   Aggarwal, N ^a   Brendler, E ^c   Fischer, S ^b   Groth, T ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c TU BERGAKADEMIE FREIBERG   (Germany)

Author keywords

Basic fibroblast growth factor; Cellulose derivatives; Heparin; Mitogenic activity

Indexed keywords

CELL PROLIFERATION; CELLULOSE; FIBROBLASTS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SULFUR COMPOUNDS;

BASIC FIBROBLAST GROWTH FACTOR; CARBOXYL GROUPS; CARBOXYMETHYL GROUP; CARBOXYMETHYLATION; CELLULOSE -DERIVATIVES; CELLULOSE SULFATES; DERIVATIZATIONS; MITOGENIC ACTIVITY; SULPHATION; SYNTHESISED;

CELL CULTURE;

CARBOXYL GROUP; CELLULOSE SULFATE; CHLOROACETIC ACID; FIBROBLAST GROWTH FACTOR; HEPARIN; BIOMATERIAL; CELLULOSE; FIBROBLAST GROWTH FACTOR 2; MITOGENIC AGENT;

ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CYTOTOXICITY; MITOGENESIS; OXIDATION; PRIORITY JOURNAL; SULFATION; SYNTHESIS; ANIMAL; CELL DIVISION; CHEMISTRY; DRUG EFFECT; MATERIALS TESTING; MOUSE; SURFACE PROPERTY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIVISION; CELL PROLIFERATION; CELLULOSE; FIBROBLAST GROWTH FACTOR 2; MATERIALS TESTING; MICE; MITOGENS; NIH 3T3 CELLS; SURFACE PROPERTIES;

EID: 77956621278     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.12.032     Document Type: Article

References (55)

1. Capila I, Linhardt RJ. Heparin-protein wechselwirkungen. Angew Chem 2002;114:426-50.
2. Garcia-Garcia MJ, Anderson KV. Essential role of glycosaminoglycans in Fgf signaling during mouse gastrulation. Cell 2003;114:727-37.
3. Xingbin A, Do AT, Lozynska O, Gullberg MK, Lindahl U, Emerson Jr CP. QSulf1 remodels the 6-O sulfation of cell surface heparin sulphate proteoglycans to promote Wnt signalling. J Cell Biol 2003;162:341-51.
4. Pye DA, Vives RR, Turnball JE, Callagher JT. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 1998;273:22936-46.
5. Schlessinger J, Plotnikov A, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000;6:743-50.
6. Coltrini D, Rusnati M, Zoppetti G, Oreste P, Grazioli G, Naggi A, et al. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Biochem J 1994;303:583-90.
7. Leali D, Belleri M, Urbinati C, Coltrini D, Oreste P, Zoppetti G, et al. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J Biol Chem 2001;276:37900-8.
8. Liekens S, Leali D, Neyts J, Esnouf R, Rusnati M, Dell'Era P, et al. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds. Mol Pharmacol 1999;56:204-13.
9. Parish CR, Freemann CF, Brown KJ, Francis DJ, Cowden WB. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 1999;59:3433-41.
10. Hatanaka K, Ohtsuki T, Kunou M. Effects of synthetic polyanions on 3T3-L1 fibroblast proliferation stimulated by fibroblast growth factors. Chem Lett 1994:1407-10.
11. Kunou M, Hatanaka K. The effect of growth factors on the cytotoxicity of sulphated polysaccharides. Carbohydr Polym 1997;34:335-42.
12. Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials 1997;18:1201-25.
13. Bürgermeister J, Paper DH, Vogl H, Linhardt RJ, Franz G. LaPSvS1, a (1-3)-β-galactan sulfate and its effect on angiogenesis in vivo and in vitro. Carbohydr Res 2002;337:1459-65.
14. Gospodarovicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 1986;128:475-84.
15. Jeon O, Kang SW, Lim HW, Chung JH, Kim BS. Long-term and zero-order release of basic fibroblast growth factor from heparin conjugated poly (L-lactide-coglycolide) nanospheres and fibrin geles. Biomaterials 2006;27:1598-607.
16. Chung YI, Tae G, Yuk SH. A facile method to prepare heparin- functionalised nanoparticles for controlled release of growth factors. Biomaterials 2006;27:2621-6.
17. Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS. Enhancement of ectopic bone formation by bone morphogenic protein-2 released from heparin conjugated poly (L-lactide-co-glycolide) scaffold. Biomaterials 2007;28:2763-71.
18. Carroll LA, Koch RJ. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts. Med Sci Monitor 2003;9: BR97-BR108.
19. Weigert C, Brodbeck K, Häring HÜ, Gambaro G, Schleicher ED. Low-molecularweight heparin prevents high-glucose and phorbol ester-induced TGF-β1 gene activation. Kidney Int 2001;60:935-43.
20. Kunou M, Hatanaka K. Effects of heparin, dextran sulphate, and synthetic (16) - α-D-mannopyranan sulphate and acidic fibroblast growth factor on 3T3-L1 fibroblasts. Carbohydr Polym 1995;28:107-12.
21. Philipp B, Wagenknecht W. Cellulose sulphate half-ester. Synthesis, structure and properties. Cell Chem Technol 1983;17:443-59.
22. Hettrich K, Wagenknecht W, Volkert B, Fischer S. New possibilities of the acetosulfation of cellulose. Macromol Symp 2008;262:162-9.
23. Saake B, Puls J, Wagenknecht W. Endoglucanase fragmentation of cellulose sulfates derived from different synthesis concepts. Carbohydr Polym 2002;48:7-14.
24. Gericke M, Liebert T, Heinze T. Interaction of ionic liquids with polysaccharides, 8-synthesis of cellulose sulfates suitable for polyelectrolyte complex formation. Macromol Biosci 2009;9:343-53.
25. Wang ZM, Li L, Xiao KJ, Wu JY. Homogeneous sulfation of bagasse cellulose in an ionic liquid and anticoagulation activity. Bioresour Technol 2009;100:1687-90.
26. Vikartovská A, Bucko M, Mislovicová D, Pätoprsty V, Lacík I, Gemeiner P. Improvement of the stability of glucose oxidase via encapsulation in sodium alginate-cellulose sulfate-poly (methylene-co-guanidine) capsules. Enzyme Microb. Technol. 2007;41:748-55.
27. Bucko M, Brygin M. Immobilization of a whole-cell epoxide-hydrolyzing biocatalyst in sodium alginate-cellulose sulfate-poly (methylene-coguanidine) capsules using a controlled encapsulation process. Enzyme Microb Technol 2006;36:118-26.
28. Stadlbauer V, Stiegler PB, Schaffellner S, Hauser O, Halwachs G, Iberer F, et al. Morphological and functional characterization of a pancreatic b-cell line microencapsulated in sodium cellulose sulfate/poly (diallyldimethylammonium chloride). Xenotransplantation 2006;13:337-43.
29. Van Damme L, Roshini Govinden MD, Mirembe FM, Taylor D. Lack of effectiveness of cellulose sulphate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008;359:463-72.
30. Yamamoto I, Takayama K, Matsuzaki K, Hatanaka K, Uryu T, Yamamoto N, et al. Synthesis, structure and antiviral activity of sulfates of cellulose and its branched derivatives. Carbohydr Polym 1991;14:53-63.
31. Groth T, Wagenknecht W. Anticoagulant potential of regioselective derivatized cellulose. Biomaterials 2001;22:2719-29.
32. Heinze T, Koschella A. Carboxylmethyl ethers of cellulose and starch-a review. Macromol Symp 2005;223:13-29.
33. Schnaubelrauch M, Heinze T, Klemm D, Nehls I, Kötz J. Investigation on synthesis and characterization of carboxy-groups containing cellulose sulfates. Polym Bull 1991;27:147-53.
34. Rabenstein DL. Heparin and heparan sulfate: structure and function. Nat Prod Rep 2002;19:312-31.
35. 13C-NMR spectroscopy. Prog Polym Sci 1994;19:29-78.
36. Wang ZM, Li L, Zheng BS, Normakhamatov N, Guo SY. Preparation and anticoagulation activity of sodium cellulose sulfate. Int J Biol Macromol 2007;41:376-82.
37. Chaidedgumjorn A, Toyoda H, Woo ER, Lee KB, Kim YS, Toida T, et al. Effect of (1 → 3)-and (1 → 4)-linkages of fully sulfated polysaccharides on their anticoagulant activity. Carbohydr Res 2002;337:925-33.
38. Socrates G. Infrared and Raman characteristic group frequencies. 3rd ed. Chichester: John Wiley; 2001.
39. Baumann H, Faust V. Concepts for improved regioselective placement of O-sulfo, N-sulfo, N-acetyl, and N-carboxymethyl groups in chitosan derivatives. Carbohydr Res 2001;331:43-57.
40. Saito T, Isogai A. TEMPO-mediated oxidation of native cellulose. The effect of oxidation conditions on chemical and crystal structures of the water-insoluble fractions. Biomacromolecules 2004;5:1983-9.
41. Saito T, Isogai A. Ion-exchange behavior of carboxylate groups in fibrous cellulose oxidized by the TEMPO-mediated system. Carbohydr Polym 2005;61:183-90.
42. Ho FFL, Kloslewicz DW. Proton nuclear magnetic resonance spectrometry for determination of substituents and their distribution in carboxymethylcellulose. Anal Chem 1980;52:913-6.
43. Baar A, Kulicke WM, Szablikowski K, Kiesewetter R. Nuclear magnetic resonance spectroscopic characterization of carboxymethylcellulose. Macromol Chem Phys 1994;195:1483-92.
44. Stigsson V, Kloow G, Germgård U. The influence of the solvent system used during manufacturing of CMC. Cellulose 2006;13:705-12.
45. Yamada T, Sawada R, Tsuchiya T. The effect of sulfated hyaluronan on the morphological transformation and activity of cultured human astrocytes. Biomaterials 2008;29:3503-13.
46. Sommer A, Rifkin DB. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a gycosaminoglycan. J Cell Physiol 1989;138:215-20.
47. Skaletz-Rorowski A, Schmidt A, Breithardt G, Buddecke E. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells. Arterioscler Thromb Vasc 1996;16:1063-9.
48. Reilly CF, Fritze LMS, Rosenberg RD. Heparin inhibition of smooth muscle cell proliferation: a cellular site of action. J Cell Physiol 1986;129:11-9.
49. Reilly CF, Kindyn MS, Brown KE, Rosenberg RD, Sonensheinn GE. Heparin prevents vascular smooth muscle cell progression through the GI phase of the cell cycle. J Biol Chem 1989;264:6990-5.
50. Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL. Competitive, reversible, and potent antagonism of inositol 1, 4, 5-trisphosphate-activated calcium release by heparin. J Biol Chem 1988;263:11075-9.
51. Miralem T, Wang A, Whiteside CI, Templeton DM. Heparin inhibits mitogenactivated protein kinase-dependent and-independent c-fos Induction in mesangial cells. J Biol Chem 1996;271:17100-6.
52. Rieck PW, Cholidis S, Hartmann C. Intracellular signaling pathway of FGF-2-modulated corneal endothelial cell migration during wound healing in vitro. Exp Eye Res 2001;73:639-50.
53. Schwartz SM, Liaw L. Growth-control and morphogenesis in the development and pathology of arteries. J Cardiovasc Pharm 1993;21: S31-49.
54. Bikfalvi A, Han ZC. Angiogenic factors are hematopoietic growth-factors and vice-versa. Leukemia 1994;8:523-9.
55. Baird A. Fibroblast growth factors: activities and significance of nonneurotrophin neurotrophic growth factors. Curr Opin Neurobiol 1994;4:78-86.